Paola Nisticò

Dr. Paola Nisticò


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in Science
Verified
Journal Article
Closed access
AFAurélie Fluckiger
Aurélie Fluckiger
RDRomain Daillère
Romain Daillère
MSMohamed Sassi
Mohamed Sassi
BSBarbara Susanne Sixt
Barbara Susanne Sixt
PLPeng Liu
Peng Liu
LZLaurence Zitvogel
Laurence Zitvogel
Phages and cancer immunity: Gut bacteria are involved in the education of T cell immune responses, and the intestinal ecosystem influences anticancer immunity. Fluckiger et al. report microbial antigens that might cross-react with antigens associated with tumor cells. They found that a type of intestinal bacteria called enterococci harbor a bacteriophage that modulates immune responses. In mouse models, administration of enterococci containing the bacteriophage boosted T cell responses after treatment with chemotherapy or programmed cell death protein 1 (PD-1) blockade. In humans, the presence of the bacteriophage was associated with improved survival after PD-1 immunotherapy. A fraction of human T cells specific for naturally processed melanoma epitopes appeared to be able to recognize microbial peptides. This “molecular mimicry” may represent cross-reactivity between tumors and microbial antigens. Science , this issue p. 936

1 February 2012 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
PNPaola Nisticò
Paola Nisticò
MBMina J. Bissell
Mina J. Bissell
DRDerek Radisky
Derek Radisky
Epithelial-mesenchymal transition (EMT) is a physiological process in which epithelial cells acquire the motile and invasive characteristics of mesenchymal cells. Although EMT in embryonic development is a coordinated, organized process involving interaction between many different cells and tissue types, aspects of the EMT program can be inappropriately activated in response to microenvironmental alterations and aberrant stimuli, and this can contribute to disease conditions including tissue fibrosis and cancer progression. Here we will outline how EMT functions in normal development, how it could be activated in pathologic conditions—especially by matrix metalloproteinases—and how it may be targeted for therapeutic benefit.

18 May 2020 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
FGFilippo Galli
Filippo Galli
JAJesus Vera Aguilera
Jesus Vera Aguilera
BPBelinda Palermo
Belinda Palermo
SMSvetomir N. Markovic
Svetomir N. Markovic
PNPaola Nisticò
Paola Nisticò
ASAlberto Signore
Alberto Signore
Tumor-infiltrating immune cells play a key role against cancer. However, malignant cells are able to evade the immune response and establish a very complex balance in which different immune subtypes may drive tumor progression, metastatization and resistance to therapy. New immunotherapeutic approaches aim at restoring the natural balance and increase immune response against cancer by different mechanisms. The complexity of these interactions and the heterogeneity of immune cell subpopulations are a real challenge when trying to develop new immunotherapeutics and evaluate or predict their efficacy in vivo. To this purpose, molecular imaging can offer non-invasive diagnostic tools like radiopharmaceuticals, contrast agents or fluorescent dyes. These agents can be useful for preclinical and clinical purposes and can overcome [18F]FDG limitations in discriminating between true-progression and pseudo-progression. This review provides a comprehensive overview of immune cells involved in microenvironment, available immunotherapies and imaging agents to highlight the importance of new therapeutic biomarkers and their in vivo evaluation to improve the management of cancer patients.

17 March 2021 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SSSheila Spada
Sheila Spada
ATAnnalisa Tocci
Annalisa Tocci
FMFrancesca Di Modugno
Francesca Di Modugno
PNPaola Nisticò
Paola Nisticò
Deciphering extracellular matrix (ECM) composition and architecture may represent a novel approach to identify diagnostic and therapeutic targets in cancer. Among the ECM components, fibronectin and its fibrillary assembly represent the scaffold to build up the entire ECM structure, deeply affecting its features. Herein we focus on this extraordinary protein starting from its complex structure and defining its role in cancer as prognostic and theranostic marker.

1 October 1997 in Experimental Cell Research
Verified
Journal Article
Closed access
RFRita Falcioni
Rita Falcioni
AAAnnalisa Antonini
Annalisa Antonini
PNPaola Nisticò
Paola Nisticò
SSStefania Di Stefano
Stefania Di Stefano
MCMarco Crescenzi
Marco Crescenzi
ASAda Sacchi
Ada Sacchi

11 April 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AMAnna Maria Mileo
Anna Maria Mileo
PNPaola Nisticò
Paola Nisticò
SMStefania Miccadei
Stefania Miccadei
Polyphenolic compounds, widely present in fruits, vegetables, and cereals, have potential benefits for human health and are protective agents against the development of chronic/degenerative diseases including cancer. More recently these bioactive molecules have been gaining great interest as anti-inflammatory and immunomodulatory agents, mainly in neoplasia where the pro-inflammatory context might promote carcinogenesis. Colorectal cancer (CRC) is considered a major public healthy issue, a leading cause of cancer mortality and morbidity worldwide. Epidemiological, pre-clinical and clinical investigations have consistently highlighted important relationships between large bowel inflammation, gut microbiota (GM), and colon carcinogenesis. Many experimental studies and clinical evidence suggest that polyphenols have a relevant role in CRC chemoprevention, exhibit cytotoxic capability vs. CRC cells and induce increased sensitization to chemo/radiotherapies. These effects are most likely related to the immunomodulatory properties of polyphenols able to modulate cytokine and chemokine production and activation of immune cells. In this review we summarize recent advancements on immunomodulatory activities of polyphenols and their ability to counteract the inflammatory tumor microenvironment. We focus on potential role of natural polyphenols in increasing the cell sensitivity to colon cancer therapies, highlighting the polyphenol-based combined treatments as innovative immunomodulatory strategies to inhibit the growth of CRC.